Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. PharmaEssentia Corporation, Taichung Plant
483
•PharmaEssentia Corporation, Taichung Plant•April 18, 2023

PharmaEssentia Corporation, Taichung Plant – FDA 483, Apr 18, 2023

Record Details

An FDA inspection conducted at PharmaEssentia Corporation ’s Taichung Plant, a drug substance manufacturer, from April 10-14 and 17-18, 2023, resulted in the issuance of a Form FDA 483 listing key observations. The findings highlight areas requiring immediate attention to ensure compliance with good manufacturing practices.

A significant concern involved the company's handling of at least 48 complaints regarding a lack of therapeutic efficacy, received between April 2022 and February 2023. Investigations into these critical complaints were found to be incomplete, lacking essential reviews of batch manufacturing records, analytical testing data, and evaluations of retention samples. Moreover, none of these investigations had been formally closed.

Additionally, the inspection identified deficiencies in the firm's bacterial endotoxin testing method, specifically the Kinetic Turbidimetric LAL Assay. The method validation failed to assess the suitability of containers used for sample collection and storage. Furthermore, the established procedure did not require the use of a calibrated timer, and an uncalibrated device was observed in use during testing. These observations underscore the need for PharmaEssentia Corporation to implement prompt and thorough corrective actions to uphold product quality and regulatory standards.

Company
PharmaEssentia Corporation, Taichung Plant
Inspection date
April 18, 2023
Product type
drugs
Office
Food and Drug Administration
Person
  • Jeffrey P. Raimondi (Consumer Safety Officer)
View Company Profile

ID · f25aed81-67c4-4875-8e10-a72bfb3b0a1e

Other documents for PharmaEssentia Corporation, Taichung Plant
  • 483 - 2023-09-21September 21, 2023
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PharmaEssentia Corporation, Taichung Plant
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.